TAG:
clinical laboratory tests
Low Lab Test Prices and Uninsured Patients
By R. Lewis Dark | From the Volume XVIII No. 3 – February 28, 2011 Issue
LOW PRICES FOR CLINICAL LABORATORY TESTS ARE CAUSING PROBLEMS for labs in California and Ohio. In this issue of THE DARK REPORT, you will learn about both situations. The California situation has gotten lots of play, but the Ohio situation is breaking news. In California, both the California Attorne…
How One Akron Physician Helped Uninsured Patients
By Joseph Burns | From the Volume XVIII No. 3 – February 28, 2011 Issue
CEO SUMMARY: For one primary care physician, treating uninsured and underinsured patients was challenging, since these patients could not afford to pay for the lab tests necessary for their healthcare. This physician enlisted the help of his local county medical society and eventually fou…
Solstas Lab Partners, DNA Direct, Pathology, Inc., Slone Partners, PAML
By Robert Michel | From the Volume XVIII No. 2 – February 7, 2011 Issue
SPECTRUM-CARILION NOW WILL BE CALLED SOLSTAS LAB PARTNERS IT IS THE NEXT STEP IN THE INTEGRATION of Spectrum Laboratory Network and Carilion Laboratories. Effective February 1, 2011, their combined businesses will use the name Solsta…
More Reimbursement Threats for Lab Testing
By R. Lewis Dark | From the Volume XVIII No. 1 – January 18, 2011 Issue
WE ARE NOW WELL INTO THE FIRST MONTH OF 2011 and already there are plenty of signs that reimbursement for both clinical laboratory testing and anatomic pathology testing will come under siege from a variety of sources this year. Take, for example, the rather rapid action by the Centers for M…
Paper Requisition Signature Rule Contradicts 2001 Actions
By Robert Michel | From the Volume XVIII No. 1 – January 18, 2011 Issue
CEO SUMMARY: Last year, the Centers for Medicare and Medicaid Services (CMS) used publication of the proposed 2011 Medicare Physician Fee Schedule to introduce new language that would require, as of January 1, 2011, that all paper requisitions for clinical laboratory tests for Me…
How Labs Should Comply With New Signature Rule
By Robert Michel | From the Volume XVIII No. 1 – January 18, 2011 Issue
CEO SUMMARY: Across the nation, clinical laboratories and pathology groups are reacting to the new Medicare rule that requires a physician signature on a paper requisition for clinical laboratory tests. Laboratories using paper requisitions will need to add a signature line, then…
New Criticisms in Ireland About Cervical Screening
By Robert Michel | From the Volume XVII No. 10 – July 12, 2010 Issue
CEO SUMMARY: Pathologists worldwide are witnessing how a government health service can erode its nation’s pathology capabilities in cytology. Ireland’s experiment in off-shoring all its Pap testing even as it requires women to register in a national database in order to get f…
Predict 60,000 Doctors To Adopt EMRs Each Year
By Robert Michel | From the Volume XVII No. 2 – January 25, 2010 Issue
CEO SUMMARY: Only about 180,000 U.S. physicians have adopted electronic medical record (EMR) systems over the past 14 years—mostly in larger medical groups. Now experts believe as many as 60,000 physicians per year will begin to adopt EMRs because of new federal incenti…
Got a Lab Test Question? Call an ASCLS Lab Guru!
CEO SUMMARY: Each year since its launch in 2001, the ASCLS Consumer Response Team serves increasing numbers of patients and physicians. Clinical Laboratory Scientist volunteers from the American Society for Clinical Laboratory Science provide answers and help patients understand …
Numerous Issues Identified With Bid Demo’s 303 Tests
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
CEO SUMMARY: One experienced expert in billing and coding was surprised at the list of 303 tests to be included in the Medicare Laboratory Competitive Bidding Demonstration Project. He notes that the list of 303 tests includes a number of codes and descriptions that are not consistent wit…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized